
Asia-Pacific journal of oncology nursing (PubMed)··Systematic Review
Oncology nurses frequently assess patients for sensory loss, numbness, and tingling during neurotoxic chemotherapy regimens. Because pharmacologic options for CIPN treatment remain limited, non-pharmacologic sensorimotor exercises that retrain proprioception and balance offer an actionable strategy to alleviate symptom distress, prevent falls, and preserve functional independence.
OncologyMed-SurgChemotherapy-induced peripheral neuropathy (CIPN) is a debilitating adverse effect of neurotoxic antineoplastic agents that frequently impairs postural stability and increases fall risk. In a PRISMA-guided systematic review and meta-analysis registered in PROSPERO (CRD42024615574), investigators searched 11 databases and two clinical trial registries through March 2026. Across 11 randomized controlled trials enrolling 548 adult cancer patients (seven studies providing quantitative meta-analytic data), sensorimotor training (SMT) was associated with significant improvements in patient-reported CIPN symptoms (standardized mean difference [SMD] = 0.54; 95% CI, 0.18-0.89) and clinician-rated neuropathy scores (SMD = 0.50; 95% CI, 0.08-0.92). SMT also produced notable improvements in balance performance (SMD = 0.79; 95% CI, 0.43-1.15), lower-extremity strength (SMD = 0.67; 95% CI, 0.30-1.04), and overall quality of life (SMD = 0.64; 95% CI, 0.34-0.94). Subgroup analysis found no significant difference between standalone SMT and multimodal exercise programs.
Key takeaways
- Meta-analysis synthesized 11 randomized controlled trials comprising 548 adult cancer patients undergoing neurotoxic chemotherapy.
- Sensorimotor training was associated with significant reductions in patient-reported (SMD 0.54) and clinician-graded (SMD 0.50) neuropathy symptoms.
- Interventions yielded substantial functional gains in postural balance (SMD 0.79) and lower-extremity muscle strength (SMD 0.67).
- Overall evidence certainty was evaluated as low per GRADE criteria due to small sample sizes, study heterogeneity, and risk of bias.
Why this matters on shift
Oncology nurses frequently assess patients for sensory loss, numbness, and tingling during neurotoxic chemotherapy regimens. Because pharmacologic options for CIPN treatment remain limited, non-pharmacologic sensorimotor exercises that retrain proprioception and balance offer an actionable strategy to alleviate symptom distress, prevent falls, and preserve functional independence.
Bedside takeaway
A meta-analysis of 11 RCTs (548 adults with cancer) found sensorimotor training significantly improved neuropathy symptoms (SMD 0.54), balance function (SMD 0.79), and quality of life (SMD 0.64), though overall evidence certainty remains low.
Nursing implications
- Screen patients receiving neurotoxic chemotherapy for numbness, paresthesias, and unsteady gait; provide early fall prevention education and collaborate with oncology physical therapy to initiate guided sensorimotor and balance exercises per facility care pathways.
Limitations & cautions
- Low certainty of evidence across outcomes per GRADE; small sample sizes across primary studies; heterogeneous training protocols and variable chemotherapy regimens precluded definitive dosing recommendations.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations · exact source links
AI-summarized from the linked source. Review the original article before applying to practice.













































